In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-18 of 18 for your search:
Drug:  vismodegib
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2010-01737, 2009-0473, U01CA062461, U01CA062491, CDR0000670590, MDA-2009-0473, 8384, NCT01163084
2.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SHH4429g, NCT00636610
3.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SHH4489g, NCT00739661
4.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SHH4476g, GO01541, NCT00833417
5.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01917, ECOG-E1508, U10CA021115, CDR0000640898, E1508, NCT00887159
6.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 22 and over
Sponsor: NCI
Protocol IDs: NCI-2012-03020, PBTC-025B, U01CA081457, CDR0000648049, NCT00939484
7.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 35 to 75
Sponsor: Other
Protocol IDs: 2009-026, SHH-4685s, NCT00957229
8.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02922, ABTC-0904, CDR0000654829, U01CA137443, 0904, NCT00980343
9.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01425, 09-0356, N01CM00071, N01CM00038, N01CM00070, CDR0000655339, NYCC-09-0356, NYU 09-0356, 8376, NCT00982592
10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 21 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01454, 09-068, RC1CA145824, N01CM00038, N01CM62201, N01CM00071, CDR0000655378, UCCRC-8418, 8418, NCT01064622
11.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: J1013, NA_00036883, NCT01088815
12.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 21 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SHH4812g, GS01354, NCT01201915
13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02564, IB-CHONDROG, CDR0000691728, NCI-8408-CHONDROG, 8408, NCT01267955
14.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: CDR0000585468, JHOC-J06131, GENETECH-SHH3925g, J06131, NCT00607724
15.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01400, MC0811, U01CA069912, MAYO-MC0811, 8231, NCT00878163
16.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SHH4610g, NCT00968981
17.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SHH4593g, GO01353, NCT01209143
18.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-03099, 09-149-B, U01CA069852, NCT01174264
New Search